SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is currently a focal point of intense investor interest as the community awaits crucial Phase 3 data for its gene editing candidate and monitors the regulatory progress of its cardiac pipeline. With short interest levels remaining elevated, investors are actively debating the potential for a volatile move driven by upcoming clinical readouts and the possibility of a squeeze.

Atomera, Inc. engages in the development, commercialization, and licensing of proprietary processes and technologies for the semiconductor industry. It developed Mears Silicon Technology, which increases performance and power efficiency in semiconductor transistors. The company was founded by Robert Mears on November 26, 2001 and is headquartered in Los Gatos, CA.

Atomera Inc

Atomera is seeing a surge in investor attention as the community anticipates news regarding potential Joint Development Agreements and commercial licensing deals tied to its Mears Silicon Technology, particularly within the Gate-All-Around and DRAM sectors. Traders are closely monitoring the stock's significant volume and price volatility, driven by speculation over partnerships with major semiconductor foundries and equipment manufacturers amid a broader focus on AI infrastructure.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is seeing a massive surge in market interest, driven by speculation over potential partnerships with major hyperscalers and its critical role in AI optical interconnects. The community is actively discussing the stock's parabolic volume and momentum, with longs celebrating the potential for a sustained breakout while shorts remain under intense pressure.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is gaining momentum as investors eye upcoming industry events and potential integration news, with the community actively debating the project's utility versus broader market volatility. Enthusiasts are focusing on long-term growth and technical accumulation, while discussion remains divided between those expecting significant adoption and others expressing caution over price trends.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRISPR Therapeutics is facing downward pressure following a series of insider share sales, which has sparked frustration among retail investors already concerned by the company's long-term capital efficiency and commercial ramp-up. Despite the negativity, the community remains divided between those calling for a strategic buyout or management change and long-term believers who are leveraging the dip to accumulate shares based on the company's extensive gene-editing pipeline and substantial cash position.

MaxLinear, Inc. engages in the provision of communications systems-on-chip (SoC) solutions used in broadband, mobile and wireline infrastructure, data center, and industrial and multi-market applications. Its products include cable broadband modems and gateways, wireline connectivity devices, radio frequency transceivers, fiber-optic modules, video set-top boxes and gateways, hybrid analog and digital televisions, direct broadcast satellite outdoor and indoor units, and power management and interface products. The company was founded by Kimihiko Imura, Curtis C. Ling, and Kishore V. Seendripu on September 25, 2003 and is headquartered in Carlsbad, CA.

MaxLinear Inc

MaxLinear is currently trending as traders aggressively reprice the stock following a significant earnings beat and raised guidance that highlights its growing role in AI-driven data center infrastructure. The community remains divided, with bulls pointing to fundamental momentum and institutional interest, while bears warn of a potential overvaluation and pump-and-dump mechanics after the recent parabolic price move.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is experiencing heightened volatility and strong community interest following a strategic collaboration with NVIDIA and Los Alamos National Laboratory, which is fueling excitement around the company's role in powering AI infrastructure. While bullish investors point to these institutional partnerships and potential regulatory catalysts as long-term drivers, others remain cautious, citing the company's pre-revenue status and recent insider selling activity.

APE fuels culture. Backed by the best club in the world and hundreds of thousands of holders worldwide, it’s the token for digital and IRL communities, builders, creators, collectors, gamers, and beyond.  APE is the native gas token of ApeChain and is available across multiple ecosystems including Ethereum, Arbitrum, Solana and HyperLiquid.z  ApeCoin's mission is is to supercharge its ecosystem by supporting high-quality builders &amp; reinforcing 3 core pillars: ApeChain, Bored Ape Yacht Club, and Otherside.

ApeCoin

ApeCoin is seeing a surge in investor attention and high-volume volatility, fueled by the launch of ApeChain and the influx of new on-chain projects. The community remains divided, with some traders highlighting the token's aggressive, flow-driven momentum while others express frustration over long-term price performance and historical dilution concerns.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

iShares Semiconductor ETF is experiencing intense volatility and record-breaking volume as traders debate whether the sector's parabolic run represents an unsustainable bubble or a continued momentum-driven surge. Community sentiment is deeply divided, with many actively hedging against a potential blow-off top while others remain focused on the sector's long-term dominance in AI infrastructure.

iHeartMedia, Inc. engages in the provision of media and entertainment services. It operates through the following segments: Multiplatform Group, Digital Audio Group, and Audio and Media Services Group. The Multiplatform Group segment consists of Broadcast radio, Networks and Sponsorships and Events businesses. The Digital Audio Group segment focuses on the Digital businesses, including Podcasts. The Audio and Media Services segment includes Katz Media Group (“Katz Media”), the company's full-service media representation business, and RCSSound Software (RCS), a provider of scheduling and broadcast software and services. The company was founded by L. Lowry Mays and B. J. McCombs in May 2007 and is headquartered in San Antonio, TX.

iHeartMedia Inc - Ordinary Shares - Class A New

iHeartMedia is seeing heightened investor attention following a report that Netflix is in merger or licensing talks, with the community closely tracking the potential for a major deal to shake up the audio and podcast landscape. Despite significant debt concerns, shareholders are actively discussing the stock's volatility and its potential for a turnaround as it explores new revenue streams and strategic partnerships.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

StockTwits For Android 

Fifty 1 Labs Inc.

Community Redevelopment Inc.

CNBX Pharmaceuticals Inc

NxGen Brands 

Hiru Corp

Resonate Blends Inc

Tianrong Internet Products and Srvcs Inc

Vocodia Holdings Corp

USA Rare Earth Inc

King

@shortlongman $FITY new company trajectory and hands on CEO retiring shares with his own money

JayDubb

StockTwits for iOS

 new company trajectory and hands on CEO retiring shares with his own money

United States Oil Fund

GameSquare Holdings Inc

Trade Desk Inc

Lemonade Inc

Lucid Group Inc

Snail Inc.

Ask My Mudda

@baker1992 I have cnbx too. So cnbx out of all?

@shortlongman I have just under 14m of $FITY and 8.5m of $CNBX

@baker1992 You been successful at otc? Either I sell crdv for fity or cnbx

 You been successful at otc? Either I sell crdv for fity or cnbx

@shortlongman successful is an ambiguous term lol. I rarely jump in these plays - last I did was about 4/5 years ago with a company called bluesphere (not sure if they even still trade but ticker symbol was $BLSP). Made over $15K on a run and sold out. I think they’re now dissolved.
The thing with these plays (IMO) is that 99.9% of the time the company will fail. Never is a long play for me. I’ve been eyeing the bid/ask on these two lately and the volume has been coming in

Naji Ahmed Ebrahim

Blue Sphere Corporation common stock

 successful is an ambiguous term lol. I rarely jump in these plays - last I did was about 4/5 years ago with a company called bluesphere (not sure if they even still trade but ticker symbol was 

). Made over $15K on a run and sold out. I think they’re now dissolved.
The thing with these plays (IMO) is that 99.9% of the time the company will fail. Never is a long play for me. I’ve been eyeing the bid/ask on these two lately and the volume has been coming in

@baker1992 I ll do same do short term hold. Now I either sell crdv for more cnbx or fifty

 I ll do same do short term hold. Now I either sell crdv for more cnbx or fifty

@shortlongman I have no bias towards either